Second-line treatment in renal cell carcinoma: clinical experience and decision making

Currently, conventional treatments for metastatic RCC (mRCC) include immune-based combination regimens and/or targeted therapies, the latter mainly acting on angiogenesis, a key element of the process of tumor growth and spread. Although these agents proved able to improve patients’ outcomes, drug r...

Descripción completa

Detalles Bibliográficos
Autores principales: Guadalupi, Valentina, Cartenì, Giacomo, Iacovelli, Roberto, Porta, Camillo, Pappagallo, Giovanni, Ricotta, Riccardo, Procopio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216352/
https://www.ncbi.nlm.nih.gov/pubmed/34211586
http://dx.doi.org/10.1177/17562872211022870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216352/
https://www.ncbi.nlm.nih.gov/pubmed/34211586
http://dx.doi.org/10.1177/17562872211022870

Ejemplares similares